Election 2014
SENSEX NIFTY
Doctor Biotech Directors Report, Doctor Biotech Reports by Directors
YOU ARE HERE > MONEYCONTROL > MARKETS > CHEMICALS > DIRECTORS REPORT - Doctor Biotech
Doctor Biotech
BSE: 512079|ISIN: INE739D01027|SECTOR: Chemicals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
Doctor Biotech is not traded in the last 30 days
Doctor Biotech is not listed on NSE
Directors Report Year End : Mar '99   
The Directors have pleasure in presenting their Fifteenth Annual Report
 together with the Audited Accounts of the Company for the year ended
 31s March, 1999.
 
 FINANCIAL RESULTS
                                           As at 31.3.99   As at 31.3.98
 
 Profit/Loss before Tax                           390873     (-)   13686
 
 Less : Provision for Tax                          32000           21000
 
                                                  358873     (-)   34686
 
 Add : Profit brought forward from
 previous year                                   1896903         1931853
 
 Add/Less : Income Tax adjustment for the
 previous years.                                  262029      (-)    264
 
 Balance carried to Balance Sheet.               1993747         1896903
 
 DIVIDEND
 
 The Directors do not recommend any Dividend for the year under review
 due to inadequate Profit earned during the year.
 
 DIRECTORS
 
 In accordance with the provision of the Companies Act, 1956 Shri.
 Shantial M Jain retire by rotation at the Annual General Meeting and is
 eligible for re-appointment
 
 PARTICULARS OF EMPLOYEES.
 
 None of the employees of the Company were in receipt of aggregating of
 remuneration by more than Rs.6,00,000/- per annum, if employed for the
 full year more than Rs. 50,000/- per month if employed for the part of
 the year.  Therefore provision of Section 217 (24) of the Companies Act
 1956 are not applicable.
 
 AUDITORS.
 
 M/s. Vijay R. Tater & Co., Chartered Accountants, Mumbai, retire at
 ensuing Annual General Meeting and are eligible for re-appointment have
 offered themselves for re-appointment, if re-appointed so.
 
 SECTION 217 (1) (e) OF THE COMPANIES ACT, 1956.
 
 The Company has no activity relating to conservation of energy or
 technology absorption.  The Company did not have any foreign exchange
 earnings expenditure.
 
 AUDITORS REPORT.
 
 The Auditors in their report have referred to the notes forming part of
 Accounts.  The said notes are self explanatory.
 
 Year 2000 Status : The Company has initiated prudent and reasonable
 steps to minimise the risk of exposure to the Y2K compliant.  The
 Financial impact on the Company as anticipated would not be material to
 its Financial or its operations.
 
 Listing of shares : The company's shares are listed with Mumbai
 stock Exchange, Dalal Street, Fort, Mumbai-23 and the listing fees for
 the year 1998-99 has been paid on time.
Source : Dion Global Solutions Limited
Quick Links for doctorbiotech
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.